MiR-22 in cardiac remodeling and disease

Trends in Cardiovascular Medicine

Volumn 24, Issue 7, 2014, Pages 267-272

  Huang, Zhan Peng ^a   Wang, Da Zhi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 22; SMALL UNTRANSLATED RNA; MICRORNA; MIRN22 MICRORNA, HUMAN;

CARDIOVASCULAR SYSTEM; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENOMICS; HEART DEVELOPMENT; HEART DISEASE; HYPERTROPHIC CARDIOMYOPATHY; MRNA EXPRESSION ASSAY; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SARCOMERE; TISSUE DISTRIBUTION; ANIMAL; CARDIOMEGALY; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; HEART VENTRICLE REMODELING; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; GENE EXPRESSION REGULATION; HEART DISEASES; HUMANS; MICRORNAS; MYOCARDIUM; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84907982578     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2014.07.005     Document Type: Review

References (57)

1. Hill J.A., Olson E.N. Cardiac plasticity. N Engl J Med 2008, 358:1370-1380.
2. Reinhart B.J., Weinstein E.G., Rhoades M.W., Bartel B., Bartel D.P. MicroRNAs in plants. Genes Dev 2002, 16:1616-1626.
3. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
4. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
5. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864.
6. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5:522-531.
7. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139.
8. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
9. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006, 103:18255-18260.
10. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
11. Chen J., Wang D.Z. MicroRNAs in cardiovascular development. J Mol Cell Cardiol 2012, 52:949-957.
12. Espinoza-Lewis R.A., Wang D.Z. MicroRNAs in heart development. Curr Top Dev Biol 2012, 100:279-317.
13. Tatsuguchi M., Seok H.Y., Callis T.E., Thomson J.M., Chen J.F., Newman M., et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007, 42:1137-1141.
14. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009, 119:2772-2786.
15. Sarac O., Gulsuner S., Yildiz-Tasci Y., Ozcelik T., Kansu T. Neuro-ophthalmologic findings in humans with quadrupedal locomotion. Ophthalmic Genet 2012, 33:249-252.
16. Christodoulou F., Raible F., Tomer R., Simakov O., Trachana K., Klaus S., et al. Ancient animal microRNAs and the evolution of tissue identity. Nature 2010, 463:1084-1088.
17. Hu Y., Matkovich S.J., Hecker P.A., Zhang Y., Edwards J.R., Dorn G.W. Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs. Proc Natl Acad Sci U S A 2012, 109:19864-19869.
18. Huang Z.P., Chen J., Seok H.Y., Zhang Z., Kataoka M., Hu X., et al. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 2013, 112:1234-1243.
19. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
20. Gurha P., Abreu-Goodger C., Wang T., Ramirez M.O., Drumond A.L., van Dongen S., et al. Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 2012, 125:2751-2761.
21. Tu Y., Wan L., Zhao D., Bu L., Dong D., Yin Z., et al. In vitro and in vivo direct monitoring of miRNA-22 expression in isoproterenol-induced cardiac hypertrophy by bioluminescence imaging. Eur J Nucl Med Mol Imaging 2014, 41:972-984.
22. Xu X.D., Song X.W., Li Q., Wang G.K., Jing Q., Qin Y.W. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. J Cell Physiol 2012, 227:1391-1398.
23. Goren Y., Kushnir M., Zafrir B., Tabak S., Lewis B.S., Amir O. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 2012, 14:147-154.
24. Jentzsch C., Leierseder S., Loyer X., Flohrschütz I., Sassi Y., Hartmann D., et al. A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol 2012, 52:13-20.
25. Gurha P., Wang T., Larimore A.H., Sassi Y., Abreu-Goodger C., Ramirez M.O., et al. MicroRNA-22 promotes heart failure through coordinate suppression of PPAR/ERR-nuclear hormone receptor transcription. PLoS One 2013, 8:e75882.
26. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
27. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
28. Song S.J., Ito K., Ala U., Kats L., Webster K., Sun S.M., et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 2013, 13:87-101.
29. Song S.J., Poliseno L., Song M.S., Ala U., Webster K., Ng C., et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013, 154:311-324.
30. Planavila A., Iglesias R., Giralt M., Villarroya F. Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res 2011, 90:276-284.
31. Huss J.M., Kelly D.P. Nuclear receptor signaling and cardiac energetics. Circ Res 2004, 95:568-578.
32. Yang J., Chen L., Yang J., Ding J., Li S., Wu H., et al. MicroRNA-22 targeting CBP protects against myocardial ischemia-reperfusion injury through anti-apoptosis in rats. Mol Biol Rep 2014, 41:555-561.
33. Xiong J., Yu D., Wei N., Fu H., Cai T., Huang Y., et al. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 2010, 277:1684-1694.
34. Ling B., Wang G.X., Long G., Qiu J.H., Hu Z.L. Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3. J Cancer Res Clin Oncol 2012, 138:1355-1361.
35. Ting Y., Medina D.J., Strair R.K., Schaar D.G. Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression. Biochem Biophys Res Commun 2010, 394:606-611.
36. Patel J.B., Appaiah H.N., Burnett R.M., Bhat-Nakshatri P., Wang G., Mehta R., et al. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene 2011, 30:1290-1301.
37. Amiel J., de Pontual L., Henrion-Caude A. miRNA, development and disease. Adv Genet 2012, 80:1-36.
38. Harper A.R., Mayosi B.M., Rodriguez A., Rahman T., Hall D., Mamasoula C., et al. Common variation neighbouring micro-RNA 22 is associated with increased left ventricular mass. PLoS One 2013, 8:e55061.
39. van Rooij E., Olson E.N. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 2012, 11:860-872.
40. Seok H.Y., Wang D.Z. The emerging role of microRNAs as a therapeutic target for cardiovascular disease. BioDrugs 2010, 24:147-155.
41. Tu Y., Wan L., Bu L., Zhao D., Dong D., Huang T., et al. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention. Cell Physiol Biochem 2013, 31:997-1008.
42. Friese R.S., Altshuler A.E., Zhang K., Miramontes-Gonzalez J.P., Hightower C.M., Jirout M.L., et al. MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension. Hum Mol Genet 2013, 22:3624-3640.
43. Xu D., Takeshita F., Hino Y., Fukunaga S., Kudo Y., Tamaki A., et al. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 2011, 193:409-424.
44. Zhang J., Yang Y., Yang T., Liu Y., Li A., Fu S., et al. MicroRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010, 103:1215-1220.
45. Jovicic A., Zaldivar Jolissaint J.F., Moser R., Silva Santos Mde F., Luthi-Carter R. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms. PLoS One 2013, 8:e54222.
46. Iliopoulos D., Malizos K.N., Oikonomou P., Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008, 3:e3740.
47. Long J., Badal S.S., Wang Y., Chang B.H., Rodriguez A., Danesh F.R. MicroRNA-22 is a master regulator of bone morphogenetic protein-7/6 homeostasis in the kidney. J Biol Chem 2013, 288:36202-36214.
48. Pandey D.P., Picard D. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 2009, 29:3783-3790.
49. Bar N., Dikstein R. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One 2010, 5:e10859.
50. Xiong J., Du Q., Liang Z. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 2010, 29:4980-4988.
51. Nagaraja A.K., Creighton C.J., Yu Z., Zhu H., Gunaratne P.H., Reid J.G., et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 2010, 24:447-463.
52. Tsuchiya N., Izumiya M., Ogata-Kawata H., Okamoto K., Fujiwara Y., Nakai M., et al. Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res 2011, 71:4628-4639.
53. Yamakuchi M., Yagi S., Ito T., Lowenstein C.J. MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS One 2011, 6:e20291.
54. Huang S., Wang S., Bian C., Yang Z., Zhou H., Zeng Y., et al. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev 2012, 21:2531-2540.
55. Jazbutyte V., Fiedler J., Kneitz S., Galuppo P., Just A., Holzmann A., et al. MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr) 2013, 35:747-762.
56. Li H.S., Greeley N., Sugimoto N., Liu Y.J., Watowich S.S. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. PLoS One 2012, 7:e52341.
57. Min S., Liang X., Zhang M., Zhang Y., Mei S., Liu J., et al. Multiple tumor-associated microRNAs modulate the survival and longevity of dendritic cells by targeting YWHAZ and Bcl2 signaling pathways. J Immunol 2013, 190:2437-2446.